JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Showing 247 Results For:
Captivate Bio's CB-N2 Supplement (100X) is a serum-free supplement optimized for the growth a variety of cells including neural cells.
Captivate Bio's Hanks' Balanced Salt Solution (HBSS) is a solution used in a variety of cell culture applications including washing, diluting, and transporting cells. This formulation is without calcium and magnesium and with phenol red.
Captivate Bio's DPBS is a balanced salt solution used for the handling and culturing of mammalian cells. Calcium and magnesium facilitate cell binding and clumping.
IL-3 Protein is a cytokine produced by activated T cells, monocytes, and stromal cells that stimulates the proliferation and differentiation of hematopoietic stem cells.
Captivate Bio's Neuro Cocktail Kit delivers the essential small molecules needed for robust neuronal differentiation, minimizing variability and simplifying protocol setup with six trusted, high-quality components.
Captivate Bio's TET-free FBS is tested to ensure the absence of detectable tetracycline, making this specialty serum ideal for cell culture applications relying on these expression systems.
XAV939 (GMP-grade) is a potent tankyrase (TNKS) inhibitor. Promotes cardiomyocyte differentiation in mesoderm progenitor cells. Also used in neuronal differentiation protocols. Produced under GMP guidelines and is ideal for cell therapy research.
IL-21 Protein, Human is produced by activated CD4+ T cells. IL-21 Protein stimulation of T cells, B cells and NK cells leads to enhanced proliferation and mature effector function.
XAV939 is a potent tankyrase (TNKS) inhibitor. Promotes cardiomyocyte differentiation in mesoderm progenitor cells. Also used in neuronal differentiation protocols.
The Sartorius MEM-NEAA (100X) solution is added as a supplement to cell culture media which stimulates growth and viability of cells in culture. This product is sold in case packs only.
